UCB7665
Showing 1 - 16 of 16
Generalized Myasthenia Gravis Trial (rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Nov 28, 2023
Myasthenia Gravis Trial in Worldwide (UCB7665, Placebo)
Completed
- Myasthenia Gravis
- UCB7665
- Placebo
-
Los Angeles, California
- +19 more
Jul 12, 2021
Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab)
Completed
- Primary Immune Thrombocytopenia
-
Boston, Massachusetts
- +26 more
Jan 16, 2023
Thrombocytopenia Trial in Worldwide (UCB7665)
Completed
- Thrombocytopenia
- UCB7665
-
Adelaide, Australia
- +28 more
Nov 26, 2020
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) Trial in Worldwide (Rozanolixizumab, Placebo)
Recruiting
- Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
- Rozanolixizumab
- Placebo
-
Scottsdale, Arizona
- +43 more
Feb 2, 2023
Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab, Placebo)
Terminated
- Primary Immune Thrombocytopenia
- Rozanolixizumab
- Placebo
-
Beverly Hills, California
- +48 more
Aug 17, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab)
Active, not recruiting
- Generalized Myasthenia Gravis
-
Orange, California
- +68 more
Jul 18, 2022
Primary Immune Thrombocytopenia Trial in Worldwide (Rozanolixizumab, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- Rozanolixizumab
- Placebo
-
Louisville, Kentucky
- +75 more
Apr 7, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Rozanolixizumab, Placebo)
Completed
- Generalized Myasthenia Gravis
- Rozanolixizumab
- Placebo
-
Phoenix, Arizona
- +91 more
Nov 25, 2021
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)
Completed
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Scottsdale, Arizona
- +13 more
Mar 31, 2022
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Rozanolixizumab)
Available
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- (no location specified)
Aug 19, 2021
Healthy Trial in Harrow (UCB7665 Intravenous 1, UCB7665 Intravenous 2, UCB7665 Intravenous 3)
Completed
- Healthy
- UCB7665 Intravenous 1
- +8 more
-
Harrow, Middlesex, United Kingdom001
Oct 2, 2015
Healthy Trial in Neuss (Rotigotine transdermal patch)
Completed
- Healthy
- Rotigotine transdermal patch
-
Neuss, NRW, Germany(unnamed)
Oct 17, 2014